EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

GalNAc-modified five-component lipid nanoparticles for liver-targeted delivery of p65 siRNA to alleviate cytokine storm in liver injury via NF-κB targeting

Zhijie Liang, Shaorong Li, Huali Huang, Shuying Luo, Hongmian Jiang, Lifeng Luo, Jinzhuai Li, Kun Zhao

Journal of Materials Chemistry B · 2026

DOI: 10.1039/d6tb00003g ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Materials Chemistry B, 2026. Verfasst von Zhijie Liang und 7 weiteren Autor:innen. Beteiligte Einrichtung: The Fifth Affiliated Hospital of Guangxi Medical University, Nanning 530000, China. Hauptthemen laut MEDLINE: RNA, Small Interfering, Nanoparticles, Acetylgalactosamine, Cytokines. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0). Gefördert von: Guangxi Zhuang Autonomous Region Health Department.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

GalNAc-modified five-component lipid nanoparticles enable liver-targeted delivery of p65 siRNA, effectively silencing NF-κB to alleviate cytokine storm and acute liver injury.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RNA, Small InterferingNanoparticlesAcetylgalactosamineCytokinesLiverTranscription Factor RelALipidsAnimalsMiceMaleMice, Inbred C57BLParticle SizeHumansHepatocytesLiposomes

Substanzen

RNA, Small InterferingAcetylgalactosamineCytokinesTranscription Factor RelALipidsLipid NanoparticlesLiposomes

Autor:innen und Institutionen

  • The Fifth Affiliated Hospital of Guangxi Medical University, Nanning 530000, China.
  • Research Institute of Lanzhou University in Shenzhen, Shenzhen 518000, China.
  • State Key Laboratory for the Chemistry and Molecular Engineering of Medicinal Resources, School of Chemistry and Pharmaceutical Sciences, Guangxi Normal University, Guilin 541004, China. ljzmedicine@163.com.
  • Departments of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning 530021, China. kundoctor@163.com.

Förderung

  • Guangxi Zhuang Autonomous Region Health Department

Zitieren

APA

Liang, Z., Li, S., Huang, H., Luo, S., Jiang, H., Luo, L., Li, J., & Zhao, K. (2026). GalNAc-modified five-component lipid nanoparticles for liver-targeted delivery of p65 siRNA to alleviate cytokine storm in liver injury via NF-κB targeting. Journal of Materials Chemistry B. https://doi.org/10.1039/d6tb00003g

Vancouver

Liang Z, Li S, Huang H, Luo S, Jiang H, Luo L, et al. GalNAc-modified five-component lipid nanoparticles for liver-targeted delivery of p65 siRNA to alleviate cytokine storm in liver injury via NF-κB targeting. Journal of Materials Chemistry B. 2026. doi:10.1039/d6tb00003g

BibTeX
@article{Liang2026,
  author = {Liang, Zhijie and Li, Shaorong and Huang, Huali and Luo, Shuying and Jiang, Hongmian and Luo, Lifeng and Li, Jinzhuai and Zhao, Kun},
  title = {GalNAc-modified five-component lipid nanoparticles for liver-targeted delivery of p65 siRNA to alleviate cytokine storm in liver injury via NF-κB targeting},
  journal = {Journal of Materials Chemistry B},
  year = {2026},
  doi = {10.1039/d6tb00003g}
}
Kostenlos starten →